Zum Hauptinhalt springen

Naltrexon

23. Dezember 2023 | Naltrexon

Naltrexone as Opioid Treatment: Who Does It Work For, Besides Cops?

Naltrexone as Opioid Treatment: Who Does It Work For, Besides Cops? Of the three Food and Drug Administration-approved medications for opioid use disorder (MOUD), two have been shown to reduce rates of overdose by more than 50 percent. Evidence for…

08. Oktober 2023 | Naltrexon

The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception.

The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception. Withey SL, Bergman J, Paronis CA. J Pharmacol Exp Ther. 2023 Sep 12:JPET-AR-2022-001570. doi: 10.1124/jpet.122.001570. Epub a…

24. September 2023 | Naltrexon

Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled trial

Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled t…

14. September 2023 | Naltrexon

Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence.

Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence. Li X, Langleben DD, Lynch KG, Wang GJ, Elman I, Wiers CE, Shi Z. Front Psychiatry. 2023 Aug 2;14:1247961…

14. September 2023 | Naltrexon

Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone.

Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone. Marciuch A, Birkeland B, Benth JŠ, Solli KK, Tanum L, Mathisen I, Weimand B. Heliyon. 2023 Jul 5;9(7):e17516. doi: 10.1016/j.heliy…

14. September 2023 | Naltrexon

Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder.

Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder. Wang L, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. J Clin Psychol. 2023 Aug 16. doi…

08. Mai 2023 | Naltrexon

Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder.

Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder. Shi Z, Li X, Kampman KM, Childress AR, Wiers CE, Langleben DD. J Clin Psychiatr…

Weitere
akutelle Informationen
zu den Themengebieten